In8bio annual r&d spending
2020
2021
2022
2023
2024
2025
In8bio R&D Spending Growth & History (INAB)
In8bio's r&d spending was $10.2M for fiscal 2025.
View full In8bio company overviewIn8bio annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.2M | −$6.8M | −39.80% |
| 2024 | 2024-12-31 | $17.0M | $135,000 | +0.80% |
| 2023 | 2023-12-31 | $16.8M | $2.8M | +19.66% |
| 2022 | 2022-12-31 | $14.1M | $6.7M | +91.40% |
| 2021 | 2021-12-31 | $7.3M | $2.0M | +36.61% |
| 2020 | 2020-12-31 | $5.4M | — | — |
In8bio quarterly r&d spending
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.5M | $6,000 | +0.24% |
| Q1 2026 | 2026-03-31 | $2.6M | −$359,000 | −12.08% |
| Q4 2025 | 2025-12-31 | $2.6M | −$946,000 | −26.32% |
| Q3 2025 | 2025-09-30 | $2.1M | −$1.2M | −36.42% |
| Q2 2025 | 2025-06-30 | $2.5M | −$2.7M | −51.76% |
| Q1 2025 | 2025-03-31 | $3.0M | −$1.9M | −39.38% |
| Q4 2024 | 2024-12-31 | $3.6M | −$928,000 | −20.52% |
| Q3 2024 | 2024-09-30 | $3.3M | −$477,000 | −12.60% |
| Q2 2024 | 2024-06-30 | $5.2M | $1.0M | +24.72% |
| Q1 2024 | 2024-03-31 | $4.9M | $518,000 | +11.81% |
| Q4 2023 | 2023-12-31 | $4.5M | $600,000 | +15.30% |
| Q3 2023 | 2023-09-30 | $3.8M | −$469,000 | −11.02% |
| Q2 2023 | 2023-06-30 | $4.1M | $630,000 | +17.98% |
| Q1 2023 | 2023-03-31 | $4.4M | $2.0M | +84.17% |
| Q4 2022 | 2022-12-31 | $3.9M | $1.2M | +45.91% |
| Q3 2022 | 2022-09-30 | $4.3M | $2.9M | +215.19% |
| Q2 2022 | 2022-06-30 | $3.5M | $1.4M | +69.77% |
| Q1 2022 | 2022-03-31 | $2.4M | $1.1M | +91.24% |
| Q4 2021 | 2021-12-31 | $2.7M | — | — |
| Q3 2021 | 2021-09-30 | $1.4M | $293,000 | +27.72% |
| Q2 2021 | 2021-06-30 | $2.1M | $280,000 | +15.70% |
| Q1 2021 | 2021-03-31 | $1.2M | — | — |
| Q3 2020 | 2020-09-30 | $1.1M | — | — |
| Q2 2020 | 2020-06-30 | $1.8M | — | — |
In8bio r&d spending trends
Over the last five fiscal years, In8bio's r&d spending increased from $5.4M to $10.2M, a change of $4.8M. The latest reported quarter, Q2 2026, shows $2.5M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review In8bio source filings ↗